United States · FDA National Drug Code directory
Cetirizine Hydrochloride (Allergy)
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58602-861_20dddc76-5ac2-498d-bff3-2d722a58891e
- Product NDC
- 58602-861
- Form
- TABLET
- Composition / generic term
- Cetirizine Hydrochloride
- Labeler
- Aurohealth LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230210
- Source listing expiry
- 20271231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (58602-861-40) · 58602-861-40
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →